Spelling suggestions: "subject:"biotechnology -- enconomic aspects."" "subject:"biotechnology -- beconomic aspects.""
1 |
A dual approach to modelling the dairy industry with predictions on the impact of bovine somatotropinHirasuna, Donald Phillip, 1960- January 1988 (has links)
This study employs duality theory to model the dairy industry. Supply and demands for milk, cull cows, feed, labor and veterinary services were simultaneously estimated using Weighted Least Squares. Elasticities and partial adjustments were obtained for the Nation and the following regions, Appalachia, Cornbelt, Northeast, Pacific, Southern Plains and Upper-Midwest. Predictions for the change in quantity of goods demanded and supplied were made assuming a parallel shift in the supply of milk and demand for feed. In conclusion, predictions on the impact of bovine Somatotropin are made assuming all results are correct.
|
2 |
The biotechnology revolution and its potential impact on the South African economySmit, Barend Schalk 12 1900 (has links)
Thesis (MBA)--Stellenbosch University, 2004. / ENGLISH ABSTRACT: In the history of the world, technological change has always played a central role in
the advancement of the global economy. Every now and then a technological
development comes along that causes a quantum leap in the technological progress
of the world. Such were the mechanical developments that led to the industrial
revolution, or the electronic developments that led to the more recent information
technology revolution. A characteristic of these developments is its profound impact
on the world economy. An explosion of new product and production possibilities
typically follows such landmark technological developments. So fast and intense are
the technological and resulting economic changes, that it can truly be described as a
revolution. Recently, the rapid advances in molecular biology have caused such a
multitude of new product and production possibilities in biological sciences that it can
be described as a biotechnology revolution.
Modern biotechnological techniques like recombinant DNA techniques have made
the genetic manipulation of organisms possible. This creates possibilities of new
production techniques and products previously unimaginable. The centre stage of
the biotechnology revolution is in the US and Europe. South Africa and other
developing countries have lagged behind in adopting and extracting economic value
from modern biotechnology.
This study investigates the issues in modern biotechnology and how the South
African economy can benefit from modern biotechnology. It was found that modern
biotechnology has tremendous economic potential and that already many overseas
companies are generating huge profits from modern biotechnology products in all
fields of biotechnology. However, some concerns about the safety of modern
biotechnology point at the necessity for a proper global regulatory framework to
ensure the consumer acceptance of biotechnology products required to continue to
extract value from new biotechnology developments. Various cost factors need to be
considered in the biotechnology industry and in South Africa the importance of these cost factors is much more pronounced due to the small scale of the South African
economy.
South Africa and many other developing countries will most definitely benefit from
adopting modern biotechnology and expanding national biotechnology capacity.
However, analyses like cost-volume-profit, economic potential, and production factor
gap analyses need to be executed, preferably up to product level, to determine the
appropriate biotechnology areas or products with the biggest economic potential and
on which South Africa should focus its biotechnology efforts.
Government stimulation of the South African biotechnology industry is welcomed by
the industry. The expansion of South African biotechnology capacity will result in
sustainable long-term economic benefits, not only to South Africa, but also to other
developing African countries.
It is concluded that the large-scale adoption of modern biotechnology in South Africa
is appropriate and that the exploding biotechnology product developments,
combined with increased market acceptance of modern biotechnology products, will
create significant economic benefits in the South African economy. / AFRIKAANSE OPSOMMING: Sedert die vroegste tye in die geskiedenis van die wereld het tegnologiese
ontwikkeling 'n sentrale rol in die vooruitgang van die wereldekonomie gespeel. Elke
nou en dan vind daar 'n tegnologiese ontwikkeling plaas wat 'n kwantumsprong in
die vooruitgang van die wereld tot gevolg he!. Voorbeelde hiervan is die meganiese
ontwikkelinge wat tot die industriele revolusie gelei het, of die meer onlangse
elektroniese ontwikkelinge wat die informasietegnologierevolusie tot gevolg gehad
het. 'n Kenmerk van hierdie ontwikkelinge is die geweldige impak wat dit op die
wereldekonomie gehad het. 'n Ontploffing in produkte en produksietegnieke is tipies
die gevolg van hierdie landmerk tegnologiese ontwikkelinge. Die tegnologiese- en
gevolglik ekonomiese veranderinge is so vinnig en intens dat dit waarlik as 'n
revolusie beskryf kan word. Die onlangse vinnige vooruitgang in molekulere biologie
het so 'n ontploffing in nuwe produkte en produksietegnieke in die biologiese
wetenskappe veroorsaak, dat dit as 'n biotegnologiese revolusie beskryf kan word.
Moderne tegnieke, soos rekombinante-DNS-tegnieke, maak die genetiese
manipulasie van organismes moontlik. Dit lei tot die ontwikkeling van nuwe produkte
en produksietegnieke wat voorheen ondenkbaar was. Die fokuspunt van die
biotegnologie-revolusie is in die VSA en Europa. Suid-Afrika en ander ontwikkelende
lande het agtergeraak in die toepassing en ekonomiese aanwending van moderne
biotegnologie.
Hierdie studie ondersoek spesifiek die kwessies in moderne biotegnologie en hoe
Suid-Afrika voordeel daaruit kan trek. Die studie het bevind dat moderne
biotegnologie geweldige ekonomiese potensiaal het en dat daar reeds baie
buitelandse maatskappye is wat groot winste in alle velde van biotegnologie
genereer. Daar is egter sekere bekommernisse oor die veiligheid van moderne
biotegnologie. Dit dui op die noodsaaklikheid van 'n deeglike globale regulatoriese
raamwerk. So 'n raamwerk sal die verbruikersaanvaarding verseker wat nodig is vir
die suksesvolle ekonomiese toepassing van moderne biotegnologie. Verskeie
kostefaktore moet in die biotegnologie-industrie in berekening gebring word en in Suid-Afrika is hierdie kostefaktore baie belangrik weens die klein skaal van die Suid Afrikaanse
ekonomie.
Suid-Afrika en baie ander ontwikkelende lande kan definitief uit die aanvaarding van
moderne biotegnologie en uitbreiding van biotegnologie-kapasiteit voordeel trek.
Analises soos koste-volume-wins-, ekonomiese potensiaal- en
produksiefaktorgapinganalises moet egter uitgevoer word, verkieslik tot op
produkvlak, om die geskikte biotegnologieveld met die grootste ekonomiese
potensiaal vir Suid-Afrika te bepaal. 'n Paar sleutel marksuksesfaktore moet in die
biotegnologiebedryf in gedagte gehou word. Die kernbeginsel van hierdie sleutel
marksuksesfaktore is geidentifiseer as die vermoe van biotegnologieprodukte om so
'n goeie waarde-aanbieding aan die klient te bied, dat die mark bereid is om 'n
premiumprys vir die produk teen ekonomies lewensvatbare vraaghoeveelhede te
betaal.
Stimulering van die Suid-Afrikaanse biotegnologiebedryf deur die regering word wyd
deur die industrie verwelkom. Die gevolglike uitbreiding van die
biotegnologiekapasiteit in Suid-Afrika sal langtermyn ekonomiese voordele vir SuidAfrika,
asook vir ander ontwikkelende lande in Afrika inhou.
Die gevolgtrekking van hierdie studie is dat grootskaalse aanvaarding van moderne
biotegnologie gepas is in Suid-Afrika en dat die ontploffing in biotegnologieprodukontwikkelings,
tesame met groter markaanvaarding van moderne
biotegnologieprodukte, groot potensiele voordele vir die toekomstige Suid-Afrikaanse
ekonomie inhou.
|
3 |
The Valuation of Agricultural Biotechnology: The Real Options ApproachFlagg, Ian Marshall January 2008 (has links)
This study develops a real options model of agbiotechnology and is applied to three genetically modified (GM) traits. Each trait is evaluated as growth options where technical or marketing milestones must be completed before management can exercise the option to invest further in trait development. The real options values are evaluated by employing a binomial tree which is simulated using distributions for random elements within stages of the growth option. Mean option values were negative for the discovery stage for fusarium-resistant wheat and for all but the regulatory submission stage for Roundup Ready wheat. The length of the regulatory submission stage had the greatest negative impact on the value of the option while the ability of the firm to maximize technology-use-fees had the greatest positive impact. Additionally, traits adapted to crops with larger potential market size are more likely to be in the money than traits developed for smaller market segments.
|
4 |
Pricing Genetically Modified Output Traits and Effects on Competing TechnologiesJohnson, Adam Michael January 2007 (has links)
This study develops a framework for pricing output traits derived from agriculture biotechnology and the effects on competing technologies post-introduction of the genetically modified (GM) variety. The price impact model determines processor or consumer adoption rates and changes in processor, farmer, and tech firm surplus as a result of the release of the new GM variety. Several implications result from this research. First, adoption of the GM variety may not be as high as expected due to the lower cost of using conventional varieties for processing or consumption inputs. Second, both processors who adopt the GM variety and those who continue to use conventional varieties will have an increase in surplus as a result
of the introduction of the GM variety. Lower costs of conventional varieties will also result in new entrants into the market.
|
5 |
The international political economy of the Cartagena Protocol on biosafetyDu Plessis, Marthinus Johannes 03 1900 (has links)
Thesis (MA)--University of Stellenbosch, 2001. / ENGLISH ABSTRACT: The development of the global biotechnology industry largely coincided with the
development of the US biotechnology industry. This resulted in this industry's
oligopolistic and centralised nature where only a few multinational chemical and
pharmaceutical companies control most biotechnology processes and production of
commodities emanating from these processes. The governance of biotechnology
has, until recently, been dominated by state actors who have endeavoured to secure
national interests, including those of large multinational corporations (MNCs) based
within their boundaries.
The technological ability of developed states to exploit and use unevenly distributed
resources to their advantage means that an uneven relationship exists between
these and poor developing countries. This has been highlighted by differences in
public opinion about the role and application of biotechnology in society. While some
opinions favour the use and application of biotechnology to enhance food supplies
and boost production levels and trade, other opinions caution against the possible
hazards that genetically manipulated organisms (GMOs) hold for the environment
and human existence.
The commercialisation of biotechnology has resulted in the exponential growth of
genetically manipulated crops in especially the United States and countries like
Argentina and Canada. These countries produce large surpluses of staple grains
such as corn and soya and try to sell these to countries with food supply problems.
The clash in commercial interests stemming from developed countries' insistence on
the protection of intellectual property rights (IPR) on genetically manipulated (GM)
seeds has caused considerable conflict with poor farmers who will not be able to
sustain their livelihoods if they cannot save seeds for future harvests.
This is one aspect of the problems surrounding the protection of knowledge products
that is exacerbated by the scientific uncertainty pertaining to the risk involved with
biotechnology. While some observers agitate for precaution with the use of GMOs,
others feel that a lack of scientific proof of harm is sufficient grounds for proceeding
with developments in biotechnology. Conversely, there are some that feel that biotechnology is market driven instead of human needs driven, ultimately resulting in
developing countries receiving very little benefit from it.
The Cartagena Protocol on biosafety was drafted to address some of the difficulties
involved with the transboundary movement of GMOs. Although it holds very specific
advantages for developing countries, as a regulatory framework it is limited in its
scope and application. Developing countries are limited in their policy options to
address their need to protect biodiversity and secure their food supply. This means
that considerable challenges and constraints await these countries in utilising global
governance of public goods and building their human and technological capacities. / AFRIKAANSE OPSOMMING: Die ontwikkeling van die globale biotegnologie-industrie het grootliks saamgeval met
die ontwikkeling van die Verenigde State se biotegnologie-industrie. Dit het
aanleiding gegee tot hierdie industrie se oligopolistiese en gesentraliseerde aard
waar slegs enkele multinasionale chemiese en farmaseutiese maatskappye die
meeste biotegnologie prosesse en die vervaardiging van kommoditeite uit daardie
prosesse beheer. Die regering van biotegnologie was tot onlangs oorheers deur
staatsakteurs wie gepoog het om nasionale belange te beskerm, insluitend die
belange van multinasionale korporasies (MNK) wat vanuit hulle grondgebied
funksioneer.
Die tegnologiese vermoë van ontwikkelde state om oneweredig verspreide
hulpbronne tot eie gewin te benut beteken dat 'n ongelyke verhouding bestaan
tussen hierdie en arm ontwikkelende state. Dit word beklemtoon deur verskille in
openbare mening oor die rol en aanwending van biotegnologie in die samelewing.
Terwyl sekere opinies ten gunste van die aanwending van biotegnologie vir die
verbetering van voedselbronne en produksievlakke en handel is, dui ander opinies
op die moontlike gevare wat geneties gemanipuleerde organismes (GMOs) vir die
omgewing en menslike voortbestaan inhou.
Die kommersialisering van biotegnologie het gelei tot die eksponensiële groei van
geneties gemanipuleerde gewasse in veral die Verenigde State en state soos
Argentinië en Kanada. Hierdie state produseer groot hoeveelhede stapelgrane soos
mielies en soja en poog om dit te verkoop aan state met
voedselvoorsieningsprobleme. Die botsing in kommersiële belange wat spruit uit
ontwikkelde state se aandrang op die beskerming van intellektuele eiendomsreg op
geneties gemanipuleerde saad veroorsaak beduidende konflik met arm landbouers
wie nie hulle lewensonderhoud kan verseker as hulle nie saad kan berg vir
toekomstige saaiseisoene nie.
Dit is een aspek van die problematiek rondom die beskerming van kennisprodukte
wat vererger word deur die wetenskaplike onsekerheid wat gepaard gaan met die
risiko's van biotegnologie. Terwyl sekere waarnemers vir waaksaamheid pleit in die gebruik van GMOs, is daar ander wat voel dat 'n gebrek aan wetenskaplike bewyse
van skade genoegsame gronde is vir die voortsetting van ontwikkelings in
biotegnologie. Insgelyks is daar diegene wat meen dat biotegnologie markgedrewe
in plaas van menslike behoefte gedrewe is, wat uiteindelik daartoe lei dat
ontwikkelende state baie min voordeel daaruit trek.
Die Kartagena Protokoloor bioveiligheid is opgestel om van die probleme betrokke
by die oorgrens verskuiwing van GMOs aan te spreek. Hoewel dit spesifieke
voordele vir ontikkelende state inhou is dit as reguleringsraamwerk beperk in omvang
en aanwending. Ontwikkelende state het beperkte beleidsopsies om hulle behoefte
om biodiversiteit te beskerm en voedselvoorsiening te verseker, aan te spreek. Dit
beteken dat beduidende uitdagings en beperkings hierdie state in die benutting van
globale regering van openbare goedere vir die bou van menslike en tegnologiese
kapasiteite in die gesig staar.
|
6 |
Environmental economics: a framework for assessing the economic impacts of adopting biotechnologies in HongKongLee, Huk-bun, 李學斌 January 2006 (has links)
published_or_final_version / Environmental Management / Master / Master of Science in Environmental Management
|
7 |
The international political economy of the Cartagena Protocol on biosafetyDu Plessis, Marthinus Johannes 03 1900 (has links)
Thesis (MA)--University of Stellenbosch, 2001. / ENGLISH ABSTRACT: The development of the global biotechnology industry largely coincided with the
development of the US biotechnology industry. This resulted in this industry's
oligopolistic and centralised nature where only a few multinational chemical and
pharmaceutical companies control most biotechnology processes and production of
commodities emanating from these processes. The governance of biotechnology
has, until recently, been dominated by state actors who have endeavoured to secure
national interests, including those of large multinational corporations (MNCs) based
within their boundaries.
The technological ability of developed states to exploit and use unevenly distributed
resources to their advantage means that an uneven relationship exists between
these and poor developing countries. This has been highlighted by differences in
public opinion about the role and application of biotechnology in society. While some
opinions favour the use and application of biotechnology to enhance food supplies
and boost production levels and trade, other opinions caution against the possible
hazards that genetically manipulated organisms (GMOs) hold for the environment
and human existence.
The commercialisation of biotechnology has resulted in the exponential growth of
genetically manipulated crops in especially the United States and countries like
Argentina and Canada. These countries produce large surpluses of staple grains
such as corn and soya and try to sell these to countries with food supply problems.
The clash in commercial interests stemming from developed countries' insistence on
the protection of intellectual property rights (IPR) on genetically manipulated (GM)
seeds has caused considerable conflict with poor farmers who will not be able to
sustain their livelihoods if they cannot save seeds for future harvests.
This is one aspect of the problems surrounding the protection of knowledge products
that is exacerbated by the scientific uncertainty pertaining to the risk involved with
biotechnology. While some observers agitate for precaution with the use of GMOs,
others feel that a lack of scientific proof of harm is sufficient grounds for proceeding
with developments in biotechnology. Conversely, there are some that feel that biotechnology is market driven instead of human needs driven, ultimately resulting in
developing countries receiving very little benefit from it.
The Cartagena Protocol on biosafety was drafted to address some of the difficulties
involved with the transboundary movement of GMOs. Although it holds very specific
advantages for developing countries, as a regulatory framework it is limited in its
scope and application. Developing countries are limited in their policy options to
address their need to protect biodiversity and secure their food supply. This means
that considerable challenges and constraints await these countries in utilising global
governance of public goods and building their human and technological capacities. / AFRIKAANSE OPSOMMING: Die ontwikkeling van die globale biotegnologie-industrie het grootliks saamgeval met
die ontwikkeling van die Verenigde State se biotegnologie-industrie. Dit het
aanleiding gegee tot hierdie industrie se oligopolistiese en gesentraliseerde aard
waar slegs enkele multinasionale chemiese en farmaseutiese maatskappye die
meeste biotegnologie prosesse en die vervaardiging van kommoditeite uit daardie
prosesse beheer. Die regering van biotegnologie was tot onlangs oorheers deur
staatsakteurs wie gepoog het om nasionale belange te beskerm, insluitend die
belange van multinasionale korporasies (MNK) wat vanuit hulle grondgebied
funksioneer.
Die tegnologiese vermoë van ontwikkelde state om oneweredig verspreide
hulpbronne tot eie gewin te benut beteken dat 'n ongelyke verhouding bestaan
tussen hierdie en arm ontwikkelende state. Dit word beklemtoon deur verskille in
openbare mening oor die rol en aanwending van biotegnologie in die samelewing.
Terwyl sekere opinies ten gunste van die aanwending van biotegnologie vir die
verbetering van voedselbronne en produksievlakke en handel is, dui ander opinies
op die moontlike gevare wat geneties gemanipuleerde organismes (GMOs) vir die
omgewing en menslike voortbestaan inhou.
Die kommersialisering van biotegnologie het gelei tot die eksponensiële groei van
geneties gemanipuleerde gewasse in veral die Verenigde State en state soos
Argentinië en Kanada. Hierdie state produseer groot hoeveelhede stapelgrane soos
mielies en soja en poog om dit te verkoop aan state met
voedselvoorsieningsprobleme. Die botsing in kommersiële belange wat spruit uit
ontwikkelde state se aandrang op die beskerming van intellektuele eiendomsreg op
geneties gemanipuleerde saad veroorsaak beduidende konflik met arm landbouers
wie nie hulle lewensonderhoud kan verseker as hulle nie saad kan berg vir
toekomstige saaiseisoene nie.
Dit is een aspek van die problematiek rondom die beskerming van kennisprodukte
wat vererger word deur die wetenskaplike onsekerheid wat gepaard gaan met die
risiko's van biotegnologie. Terwyl sekere waarnemers vir waaksaamheid pleit in die gebruik van GMOs, is daar ander wat voel dat 'n gebrek aan wetenskaplike bewyse
van skade genoegsame gronde is vir die voortsetting van ontwikkelings in
biotegnologie. Insgelyks is daar diegene wat meen dat biotegnologie markgedrewe
in plaas van menslike behoefte gedrewe is, wat uiteindelik daartoe lei dat
ontwikkelende state baie min voordeel daaruit trek.
Die Kartagena Protokoloor bioveiligheid is opgestel om van die probleme betrokke
by die oorgrens verskuiwing van GMOs aan te spreek. Hoewel dit spesifieke
voordele vir ontikkelende state inhou is dit as reguleringsraamwerk beperk in omvang
en aanwending. Ontwikkelende state het beperkte beleidsopsies om hulle behoefte
om biodiversiteit te beskerm en voedselvoorsiening te verseker, aan te spreek. Dit
beteken dat beduidende uitdagings en beperkings hierdie state in die benutting van
globale regering van openbare goedere vir die bou van menslike en tegnologiese
kapasiteite in die gesig staar.
|
8 |
A promise or a threat? : a theological critique of genetic engineering and biotechnology with particular reference to food security and sovereignty in Africa.Chingondole, Samuel Mpeleka. January 2002 (has links)
Today, Africa has more countries with food security problems than any other region on the globe. Two-thirds of all countries suffering food insecurity are in Africa. Present trends would mean that the number of chronically undernourished people in the Southern region of Africa would rise from 180 to 300 million by the year 2010.
In this research, I note that in the face of this food or hunger crisis, particularly in Africa, some have argued that genetic engineering biotechnology promises to combat food insecurity. Opponents of the technology argue that, to the contrary, genetic engineering biotechnology undermines food security, food sovereignty and livelihoods on the continent. The technology is designed to block access to food and kill agricultural biodiversity, vest excessive, monopolistic and exclusive power in the hands of a few biotechnologists and giant multinational corporations, and ultimately, create hunger and poverty in Africa and other developing countries by undermining organic and conventional means of farming.
The thesis offers a critical theological assessment of the structural, ecological and socioeconomic effects of genetic engineering and biotechnology on agriculture, food production, food security and sovereignty in Africa against some core theological principles. The study, therefore, brings a careful critique to the growing area of science in its relationship to the current issues of food security and sovereignty. The theological framework provides a moral framework for analysis that can be applied in the debate about genetic engineering and biotechnology. In this thesis, I will consistently demonstrate that opponents of the GE technology think that proponents of r-DNA technology are mostly driven by the intent to generate and maximize profits rather than a concern for the common well being, and the intent to control all the stages of agricultural production. The corporate control over essential agricultural resources such as seeds and food entails that multinational companies have control over fundamental human rights of access to healthy, safe and adequate food, nutrition, and ultimately to social and economic development itself. This, then, becomes an issue of justice and hence the concern of the churches and theologians. In this light, then, the study argues that issues of food security and sovereignty cannot be meaningfully and credibly pursued without taking adequate recognition of moral, ethical and theological insights. Such framework would guide scientific and GE technological
activities. / Thesis (M.Th.)-University of Natal, Pietermaritzburg, 2002.
|
Page generated in 0.2099 seconds